Venture Map · Round
Veritas Intercontinental — Series B · €5M
Announced 2020-10-15 · Madrid · Genomics / Preventive medicine
Veritas Intercontinental is a spin-off of Veritas Genetics offering whole-genome sequencing (myGenome); Charme Capital Partners and Amadeus Capital Partners co-led the round. It pays for the company's own labs and R&D and takes total capital raised past €20M. Some sources call this round a Series A.
RoundSeries B
Amount€5M
LeadNot disclosed
Date2020-10-15
CityMadrid
SectorGenomics / Preventive medicine
The company
Investors 4
AAmadeus Capital Partners
C
Charme Capital Partners
G
Graham Snudden
S
Stemar Capital Partners
